Medpace Holdings (MEDP) Cash from Operations (2015 - 2026)

Medpace Holdings (MEDP) has reported Cash from Operations for 12 consecutive years, with $162.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 9.08% year-over-year to $162.0 million; the trailing twelve-month figure through Jun 2026 stood at $752.7 million (up 22.56% YoY), and the FY2025 full-year result was $713.2 million, up 17.15% from the prior year.
• Cash from Operations climbed to $162.0 million in Q2 2026 per MEDP's latest filing, from $151.8 million in the prior quarter.
• Across five years, Cash from Operations topped out at $246.2 million in Q3 2025 and bottomed at $46.3 million in Q1 2022.
• Historically, Cash from Operations has averaged $136.5 million across 5 years, with a median of $142.6 million in 2022.
• The widest YoY moves for Cash from Operations: up 92.8% in 2022, down 19.3% in 2022.
• Over 5 years, Cash from Operations stood at $136.7 million in 2022, then grew by 14.42% to $156.4 million in 2023, then increased by 21.91% to $190.7 million in 2024, then rose by 1.04% to $192.7 million in 2025, then dropped by 15.9% to $162.0 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered $162.0 million, $151.8 million, and $192.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.